West Pharmaceutical Services PE Ratio 2010-2023 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of April 22, 2024 is 46.45.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-23 390.20 49.52
2023-12-31 351.75 $7.88 44.64
2023-09-30 374.82 $7.41 50.58
2023-06-30 381.88 $6.86 55.67
2023-03-31 345.75 $7.28 47.49
2022-12-31 234.69 $7.72 30.40
2022-09-30 245.18 $8.29 29.58
2022-06-30 301.08 $9.01 33.42
2022-03-31 408.77 $9.00 45.42
2021-12-31 466.56 $8.70 53.63
2021-09-30 422.14 $8.06 52.38
2021-06-30 356.91 $6.84 52.18
2021-03-31 279.91 $5.58 50.16
2020-12-31 281.27 $4.58 61.41
2020-09-30 272.76 $4.13 66.04
2020-06-30 225.27 $3.79 59.44
2020-03-31 150.83 $3.46 43.59
2019-12-31 148.77 $3.20 46.49
2019-09-30 140.19 $3.05 45.96
2019-06-30 123.56 $3.03 40.78
2019-03-31 108.66 $2.90 37.47
2018-12-31 96.52 $2.75 35.10
2018-09-30 121.41 $2.06 58.94
2018-06-30 97.49 $2.00 48.75
2018-03-31 86.56 $1.76 49.18
2017-12-31 96.60 $1.99 48.54
2017-09-30 94.10 $2.51 37.49
2017-06-30 92.27 $2.34 39.43
2017-03-31 79.54 $2.43 32.73
2016-12-31 82.55 $1.92 43.00
2016-09-30 72.37 $1.85 39.12
2016-06-30 73.60 $1.37 53.72
2016-03-31 67.12 $1.15 58.37
2015-12-31 58.19 $1.30 44.76
2015-09-30 52.18 $1.28 40.76
2015-06-30 55.90 $1.69 33.08
2015-03-31 57.83 $1.83 31.60
2014-12-31 51.03 $1.76 28.99
2014-09-30 42.80 $1.66 25.78
2014-06-30 40.23 $1.60 25.14
2014-03-31 41.92 $1.51 27.76
2013-12-31 46.59 $1.58 29.49
2013-09-30 39.00 $1.55 25.16
2013-06-30 33.21 $1.40 23.80
2013-03-31 30.60 $1.19 25.71
2012-12-31 25.71 $1.15 22.45
2012-09-30 24.83 $1.12 22.27
2012-06-30 23.54 $1.15 20.56
2012-03-31 19.74 $1.21 16.38
2011-12-31 17.53 $1.08 16.23
2011-09-30 17.06 $0.90 18.95
2011-06-30 20.04 $0.91 22.03
2011-03-31 20.43 $0.94 21.85
2010-12-31 18.72 $0.94 19.92
2010-09-30 15.52 $1.15 13.55
2010-06-30 16.43 $1.14 14.41
2010-03-31 18.82 $1.12 16.88
2009-12-31 17.51 $1.06 16.52
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $27.478B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.294B 18.55
Becton Dickinson (BDX) United States $67.568B 19.62
Cardinal Health (CAH) United States $25.012B 15.03
Align Technology (ALGN) United States $22.637B 45.65
Cooper (COO) United States $17.896B 27.08
Labcorp (LH) United States $17.083B 14.59
Henry Schein (HSIC) United States $9.256B 16.01
DENTSPLY SIRONA (XRAY) United States $6.298B 16.60
Merit Medical Systems (MMSI) United States $4.253B 24.34
Patterson (PDCO) United States $2.321B 11.12
STAAR Surgical (STAA) United States $2.275B 71.61
CONMED (CNMD) United States $2.236B 21.05
Atrion (ATRI) United States $0.704B 36.25
Lifevantage (LFVN) United States $0.078B 12.60
Pro-Dex (PDEX) United States $0.065B 24.72
Biolase (BIOL) United States $0.005B 0.00